Bioengineering Breakthroughs: Cornea Repair, Bioplastics, and Robotic Surgery

Overview

This post highlights a Royal Institution lecture by a bioengineer who envisions a world led by bioengineers, where life-like tissues are built from collagen and biodegradable materials to repair the body and heal the planet. The talk covers cornea repair, alignment of collagen architectures, bioplastics, eggshell membrane sources, and the future of surgery with robotic tools.

Key insights

• Cornea repair using stem cells and collagen scaffolds can reduce donor tissue demand and expand access to vision-restoring therapies.
• Techniques like plastic compression and horizontal shear flow enable rapid, strong, and transportable collagen-based tissues that mimic native architecture.
• Bioplastics and greener nanoparticle technologies offer eco-friendly options for wound dressings and antimicrobial surfaces.
• Emerging robotic and endoluminal surgical tools promise safer, less invasive procedures and broader access to advanced surgery.

Introduction and context

The speaker, a seasoned bioengineer and entrepreneur, shares a vision of bioengineers leading a world where biology and engineering merge to heal people and the planet. Framed within the Royal Institution tradition of demos and public science, the talk emphasizes cross-disciplinary collaboration among scientists, engineers, and industry to deliver real-world health solutions. The central thread is that bioengineering leverages cells, materials, and environmental cues to recreate or repair biological tissues, while also prioritizing sustainability through biodegradable materials and renewable sources.

Three pillars of engineered tissues

Developing functional tissues requires three key ingredients: (1) cells sourced from donor tissue or stem-cell banks, (2) a suitable scaffold or matrix that cells can attach to and reside within, and (3) a physiologically relevant environment that provides mechanical cues, topographical cues, and biochemical growth factors. The speaker explains how tissue formation is guided not only by the composition of the scaffold but also by its architecture and the mechanical and biochemical signals it presents, which direct cell behavior and tissue maturation.

Cornea repair and collagen scaffolds

The lecture details work conducted at Moorfields Eye Hospital and University College London focused on repairing corneal damage caused by chemical injuries or genetic diseases. The cornea’s transparency hinges on a highly organized collagen-rich stroma whose basket-weave structure guides light to the retina. Scarred or damaged corneas lose transparency, leading to blindness. Given the limited donor supply (for example, the UK’s demand requires many dozens of corneas per week), the team explored cell-based strategies to generate a bank of corneal cells that can be used to fabricate transplanted tissues or grafts. The discussion covers acquiring donor tissue, isolating stromal cells, expanding them in culture, and forming tissue that retains the essential collagen organization for light transmission.

From jelly to tissue: collagen scaffolds and plastic compression

Collagen gels serve as an initial, soft matrix to culture cells, but their softness and water content limit mechanical strength. The researchers developed a simple yet powerful plastic compression method to densify collagen gels by removing water, thereby increasing collagen density and turning a jelly-like gel into a thin, suture-friendly membrane. This approach enables rapid, repeatable tissue fabrication and better suitability for surgical transplantation. Over time this process was standardized into commercial-ready formats suitable for clinical use, reducing infection risk and enabling direct seeding of cells on the compressed collagen membranes.

Aligning collagen architecture through engineering

Beyond corneas, native tissues often feature highly aligned connective tissues. The team explored mimicking this alignment by inspiration from everyday tools, notably a pasta maker. They designed a simple roller-based horizontal shear flow technique to align collagen fibrils on the gel surface, which was confirmed using advanced microscopy. Cells seeded on these aligned gels followed the same alignment, showing that the scaffold can instruct cell organization and subsequent matrix deposition. The project progressed from a hands-on prototype to more standardized devices to ensure reproducibility and regulatory readiness.

Bioplastics and greener materials

The discussion moves to biodegradable materials and greener chemistry. Bioplastics derived from renewable sources like plants and algae reduce dependence on fossil fuels and enable more sustainable medical devices. The collaboration with bioplastic researchers allowed embedding greener nanoparticles into collagen membranes and bioplastics, aiming to improve antimicrobial properties and healing outcomes while maintaining biocompatibility.

Eggshell membrane as a sustainable collagen source

An intriguing pivot of the talk is the eggshell membrane, a waste by-product rich in collagen and endowed with anti-inflammatory properties. This material offers a sustainable alternative for wound dressings and tissue implants. The presenter explains collaborations that explore embedding green nanoparticles into eggshell membranes, aiming to modulate antimicrobial activity and tissue compatibility. The eggshell membrane is highlighted as a practical example of turning waste into valuable medical material, aligned with sustainability goals.

The future of surgery

The talk concludes with a look at the evolution of surgical practice toward robotics and endoluminal approaches. While open surgery required large incisions, minimally invasive techniques and robotic assistance have transformed operative care. The speaker envisions endoluminal surgery becoming more capable through new robotic tools that work within natural pathways, potentially transforming treatment for colorectal cancer. A key project introduced is Serpenta, a startup developing the next generation surgical robot for operating anywhere in the colon, enabling precise, less invasive cancer treatment with backing from Zinc Venture Capital. The overarching message is that technology, biology, and thoughtful design can make surgery smarter, safer, and more accessible globally.

Closing reflections

Throughout the lecture the speaker emphasizes the importance of collaboration, regulation, and real-world impact. The final message honors the Royal Institution and the community of researchers and supporters who contribute to a future where health outcomes improve while preserving planetary health. The talk closes with gratitude and a call to nurture curiosity in the next generation of scientists and engineers.